Dr Sreejith Raveendran will join the group in October

Dr Sreejith Raveendran is a Marie Skłodowska-Curie Fellow who will join the group in October to work on the developing novel nanoparticle based formulations for cancer treatment.

Dr  Raveendran graduated with his PhD in Bionanoscience with an emphasis on cancer drug delivery and nanomedicine from Toyo University, Japan in 2013. After acquiring his doctoral degree from Bio Nano Electronics Research centre, he is pursuing his nanoresearch in cancer nanotechnology and targeted nanotherapy through the postdoctoral research position.

Leave a Reply

Your email address will not be published.